Pacific Biosciences of California Inc

Most Recent

  • uploads///Graph Part  Dec
    Company & Industry Overviews

    XBI Recovers from Its Slump

    The SPDR S&P Biotech ETF (XBI) and the iShares Nasdaq Biotechnology ETF (IBB) were the top biotechnology ETFs last week, returning 5.3%, and 3.7%.

    By Peter Neil
  • uploads///hands _
    Company & Industry Overviews

    Pacific Biosciences of California Rose 67.63% on November 2

    On November 2, Pacific Biosciences of California (PACB) closed at $7.56, which was 67.63% higher than its previous closing price.

    By Margaret Patrick
  • uploads///puzzle _
    Company & Industry Overviews

    Why Is Pacific Biosciences Stock Up ~6.2% Today?

    Today, Pacific Biosciences of California (PACB) is trading at $5.16 per share, up ~6.17% from yesterday’s close of $4.86.

    By Daniel Collins
  • uploads///stock price comparison
    Company & Industry Overviews

    What’s behind Thermo Fisher’s Rumored Acquisition of Illumina?

    On August 18, 2016, Illumina (ILMN) rose more than 3% amid rumors of Thermo Fisher Scientific (TMO) acquiring Illumina for $30 billion in an all-stock deal.

    By Sarah Collins
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.